Main container

PROfilazione GENomica a scopo terapeutico nei SARComi e molecular tumor board (MTB): studio retrospettivo/prospettico in centri di riferimento

Title
PROfilazione GENomica a scopo terapeutico nei SARComi e molecular tumor board (MTB): studio retrospettivo/prospettico in centri di riferimento
Code
PROGEN_SARC
Type
Osservazionale
Start Year
2022
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Description

Tutti i medici oncologi dell'Osteoncologia sono co-investigator e quindi arruolano pazienti per questo studio.

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
05/07/2022 12:06